Print Page

Products found to contain undeclared medicines

Singapore: HSA Alert: 'Ke Le' weight loss product sold online found to contain potent medicines used to treat cough and blocked nose
The Health Sciences Authority (HSA) is alerting members of the public not to purchase or consume the product marketed as ‘Ke Le’ (‘可乐’), which was sold online and promoted as an appetite suppressant for weight loss. The product packaging was labelled in Korean. HSA tested the product and found it to contain two undeclared potent medicinal ingredients, ephedrine and pseudoephedrine, which could pose serious health risks in individuals with heart conditions.

Ephedrine and pseudoephedrine are used as medicines to relieve blocked nose and cough for the treatment of common cold, flu and allergies. Based on the seller’s recommended dosing instructions, the amount of ephedrine taken per day by unknowing consumers would have been more than four times the limit for the treatment of common cold, flu and allergies. Such dangerously high levels of ephedrine can cause serious and life-threatening adverse effects, especially in consumers with existing medical conditions (e.g. high blood pressure, heart problems, thyroid disease) and when taken together with caffeine-containing products. These adverse effects include increased heart rate, anxiety, insomnia, high blood pressure, stroke, seizures and even death.

Consumers are advised to stop taking ‘Ke Le’ (‘可乐’) immediately. Consult a doctor if they feel unwell or are concerned about their health.

Please refer to the following website in HSA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Friday, Sep 14, 2018
Issued at HKT 16:00